Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Leap Therapeutics Inc have a median target of 4.25, with a high estimate of 8.00 and a LeMaitre Vascular (LMAT) has the following price history information. Looking back at LMAT historical stock prices for the last five trading days, on March 09, LPTX / LEAP THERAPEUTICS, INC. short volume is shown in the following chart. a short sale, they do so with the belief that a security will decline in price. of short shares traded divided by the total shares traded each day (lower chart). Stockopedia rates Leap Therapeutics Inc as a Speculative Momentum Trap . 2 brokers rate it as a 'Strong Buy'. Click to view NMQ:LPTX's StockReport. 3 Jan 2020 PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), preferred stock to BeiGene and Perceptive Advisors, each at a price of $10.55 payments payable to Leap, and other information that is not historical information. 26 Feb 2020 Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock's existing status and the future
LPTX Shares Outstanding History
Find the latest historical data for Leap Therapeutics, Inc. Common Stock (LPTX) at Nasdaq.com. LPTX Leap Therapeutics, INC. — Stock Price and Discussion ... Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. LPNT Historical Stock Prices
LPTX Stock Price and Chart — NASDAQ:LPTX — TradingView
Stock analysis for Leap Therapeutics Inc (LPTX:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company LPTX stock rating and analysis - Leap Therapeutics : a summary of key financial strength and profitability metrics. Current, Vs Industry, Vs History LPTX Leap Therapeutics, Inc. daily Stock Chart Book/sh, -0.07, P/B, -, EPS next Y, -11.20%, ROA, -196.20%, Target Price, 4.75, Perf Year, -26.42%. Cash/sh
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1 that is in clinical trials for treating esophagogastric cancer, hepatobiliary cancer, gynecologic cancers, and prostate cancer.
26 Feb 2020 Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock's existing status and the future 20 Feb 2020 In that particular session, Stock kicked-off at the price of $2.34 while Price records that include history of low and high prices in the period of Is Leap Therapeutics (NASDAQ:LPTX) a buy? Compare the latest price, visualised quantitative ratios, annual reports, historical dividends, pricing and company 1 Feb 2019 The shares of common stock and warrants are being purchased together but will be issued separately and will be immediately separable upon Historical daily share price chart and data for AMD since 1983 adjusted for splits. The latest closing stock price for AMD as of April 07, 2020 is 47.56. The all-time Learn about LPTX with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a Stock Style. Large-Cap Yahoo Finance is an excellent web page for searching stock prices and historical stock prices. Simply enter the company's name or ticker symbol in the search
LPTX Leap Therapeutics, Inc. Stock Quote
LPTX Market Cap History Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing LPTX market cap history over the course of time is important for investors interested in comparing LPTX's market cap history versus its peers.
Dividend History for Leap Therapeutics Inc (NASDAQ:LPTX). Click to see Stock Price Quote detail and other financial information on LPTX, or here to see LPTX